Search

everythinglearnresearchcommunity

for

Search:↓

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Various treatments exist for hair loss, but more research is needed for better options.

New drug delivery methods can make natural compounds more effective and stable.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Hair loss is a common side effect of hormone treatments for cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.